Faculty

Keith Kaye

MD, MPH
Professor
Rutgers Robert Wood Johnson Medical School

Dr. Kaye is the Chief, Division of Allergy, Immunology and Infectious Diseases, and is Professor of Medicine iRutgers Robert Wood Johnson Medical School.
He has devoted his career to the prevention and effective management of healthcare-associated infections (HAIs). In addition to serving in a variety of quality improvement and administrative roles in infection prevention, antimicrobial stewardship, and quality and patient safety, he has served on national and international clinical guidelines committees.
Dr. Kaye’s research interests include prevention and treatment of antimicrobial resistant organisms, prevention of healthcare associated infections, and innovative approaches to antimicrobial stewardship. He has a long and productive track record of federal funding for research (including innovative clinical trials) pertaining to management of HAIs and multi-drug resistant organisms (MDROs) including Acinetobacter baumannii, carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa. He has conducted groundbreaking clinical trials on HAIs and MDROs.
Dr. Kaye received his medical degree from the University of Pennsylvania and completed Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center. He earned a Masters in Public Health from the Harvard School of Public Health. He has published more than 400 peer-reviewed articles and more than 20 book chapters. He frequently presents original research at international conferences. Dr. Kaye is past President of the Society for Health Epidemiology of America. He is an internationally recognized expert in HAI and MDROs and has been invited to speak on these topics around the world. He has mentored more than 100 faculty, trainees, and students.

2024 Sessions

ISS: Strategies for ABSSSI Management in Adults: Harnessing Tetracyclines Through an Interdisciplinary Approach

Supported by an unrestricted educational grant from Paratek Pharmaceuticals, Inc.<br>
1.00 CME/CNE/CPME<br><br>

Learning objectives:<br>
1. Correlate the increase of ABSSSI with increased morbidity, mortality, length of hospital stay, and overall costs.<br>
2. Explain the mechanisms of action of tetracycline-class antibacterials and describe their spectrum of activity against common pathogens associated with ABSSSI.<br>
3. Examine current trends in antibiotic resistance relevant to ABSSSI, including the prevalence of resistant strains and how tetracyclines compare to other antibiotic classes.

ISS Speaker

Wednesday, November 05 1:30–2:30 PM
Faculty

Keith Kaye

MD, MPH
Professor
Rutgers Robert Wood Johnson Medical School

Dr. Kaye is the Chief, Division of Allergy, Immunology and Infectious Diseases, and is Professor of Medicine iRutgers Robert Wood Johnson Medical School.
He has devoted his career to the prevention and effective management of healthcare-associated infections (HAIs). In addition to serving in a variety of quality improvement and administrative roles in infection prevention, antimicrobial stewardship, and quality and patient safety, he has served on national and international clinical guidelines committees.
Dr. Kaye’s research interests include prevention and treatment of antimicrobial resistant organisms, prevention of healthcare associated infections, and innovative approaches to antimicrobial stewardship. He has a long and productive track record of federal funding for research (including innovative clinical trials) pertaining to management of HAIs and multi-drug resistant organisms (MDROs) including Acinetobacter baumannii, carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa. He has conducted groundbreaking clinical trials on HAIs and MDROs.
Dr. Kaye received his medical degree from the University of Pennsylvania and completed Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center. He earned a Masters in Public Health from the Harvard School of Public Health. He has published more than 400 peer-reviewed articles and more than 20 book chapters. He frequently presents original research at international conferences. Dr. Kaye is past President of the Society for Health Epidemiology of America. He is an internationally recognized expert in HAI and MDROs and has been invited to speak on these topics around the world. He has mentored more than 100 faculty, trainees, and students.

Loan Lam

DPM, FAWPHc, FAPWCA, CWSP, CHWS, CLWT
Medical Director of Wound Services
United Vein and Vascular Centers

Loan Lam DPM FAWPHc FAPWCA CWSP CHWS CLWT

Dr. Loan Lam is the Medical Director of Wound Services at United Vein and Vascular Centers. She graduated from Rice University, received her medical degree from Barry University, and completed her podiatric surgical residency at Yale New Haven Health System in New Haven, CT. She is certified in wound, hyperbaric medicine, and lymphedema therapy. She has authored several articles in peer-reviewed journals, presented numerous wound conference research posters, is a PI for multiple clinical research trials, and is a national and international speaker on behalf of several organizations.

Dr. Lam is a member of the American Vein and Lymphatic Society, National Lymphedema Network, Wound Healing Society, Wound Care Collaborative Community, American Professional Wound Care Association, and Academy of Physicians in Wound Healing. She is a long-time volunteer and board member of the American Cancer Society. She also serves on the board of the Save a Leg, Save a Life Foundation. Besides medicine, her wonderful family, multiple pets, and family farm, her other loves include running races and playing amateur hockey.

Back to top